Ultralife (ULBI) Earnings Analysis

Ultralife (ULBI) next reports earnings on 2026-07-23, consensus EPS 0.19 USD. Last quarter (2026-05-08) it missed with EPS -0.03 USD vs 0.15 USD est (-120%). It has beaten estimates in 1/8 recent quarters (13%). Trailing P/E -10.94.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ULBI next report earnings?

Next earnings date2026-07-23
Consensus EPS estimate0.19 USD
Revenue estimate0.06B

ULBI earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-08-0.03 USD0.15 USD-120%Miss
2026-03-100.12 USD0.24 USD-50%Miss
2025-11-18-0.07 USD0.21 USD-133.3%Miss
2025-08-070.07 USD0.22 USD-68.2%Miss
2025-05-090.13 USD0.15 USD-13.3%Miss
2025-04-010.01 USD0.15 USD-93.3%Miss
2024-11-080.01 USD0.21 USD-95.2%Miss
2024-07-250.22 USD0.14 USD+57.1%Beat

Beat rate: 1/8 (13%) over reported quarters with consensus data.

ULBI valuation and analyst view

Trailing P/E-10.94
Trailing EPS-0.49313 USD
Price / book0.70
Dividend yield0.00%
Market cap0.09B
Analyst consensusBuy (1 buy / 0 hold / 1 sell)

Related research pages

Frequently asked questions

When is Ultralife (ULBI)'s next earnings date?

Ultralife is next scheduled to report on 2026-07-23, with a consensus EPS estimate of 0.19 USD and revenue estimate of 0.06B.

Did ULBI beat earnings last quarter?

In its 2026-05-08 report, ULBI posted EPS of -0.03 USD versus a 0.15 USD estimate — a miss of 120%.

What is ULBI's earnings track record?

Over the last 8 reported quarters with consensus data, ULBI beat estimates 1 times (13%).

What is ULBI's current P/E ratio and EPS?

ULBI trades at a trailing P/E of -10.94 on trailing EPS of -0.4931260130875908 USD.

What do analysts rate ULBI?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 1 buy, 0 hold, 1 sell, 0 strong sell).